Hikma Pharmaceuticals PLC (HIK) - Total Assets

Latest as of June 2025: GBX5.55 Billion GBX ≈ $675.76K USD

Based on the latest financial reports, Hikma Pharmaceuticals PLC (HIK) holds total assets worth GBX5.55 Billion GBX (≈ $675.76K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Hikma Pharmaceuticals PLC - Total Assets Trend (2002–2024)

This chart illustrates how Hikma Pharmaceuticals PLC's total assets have evolved over time, based on quarterly financial data. Also see Hikma Pharmaceuticals PLC market capitalisation for the company's overall valuation and market capitalisation.

Hikma Pharmaceuticals PLC - Asset Composition Analysis

Current Asset Composition (December 2024)

Hikma Pharmaceuticals PLC's total assets of GBX5.55 Billion consist of 44.1% current assets and 55.9% non-current assets. Review total liabilities of Hikma Pharmaceuticals PLC to assess the company's total debt and financial obligations.

Asset Category	Amount (GBX)	% of Total Assets
Cash & Equivalents	GBX0.00	3.7%
Accounts Receivable	GBX905.00 Million	17.6%
Inventory	GBX986.00 Million	19.2%
Property, Plant & Equipment	GBX0.00	0.0%
Intangible Assets	GBX774.00 Million	15.1%
Goodwill	GBX382.00 Million	7.4%

Asset Composition Trend (2002–2024)

This chart illustrates how Hikma Pharmaceuticals PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See HIK stock price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Hikma Pharmaceuticals PLC's current assets represent 44.1% of total assets in 2024, a decrease from 67.9% in 2002.
Cash Position: Cash and equivalents constituted 3.7% of total assets in 2024, down from 12.8% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 0.0% in 2002.
Asset Diversification: The largest asset category is inventory at 19.2% of total assets.

Hikma Pharmaceuticals PLC Competitors by Total Assets

Key competitors of Hikma Pharmaceuticals PLC based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Beijing Tongrentang Co Ltd SHG:600085	China	CN¥31.82 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Neuland Laboratories Limited NSE:NEULANDLAB	India	Rs29.30 Billion
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	China	CN¥17.01 Billion

Hikma Pharmaceuticals PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.24	1.66	1.76
Quick Ratio	0.72	0.98	1.12
Cash Ratio	0.00	0.00	0.00
Working Capital	GBX501.00 Million	GBX905.00 Million	GBX808.00 Million

Hikma Pharmaceuticals PLC - Advanced Valuation Insights

This section examines the relationship between Hikma Pharmaceuticals PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.82
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	9.7%
Total Assets	GBX5.13 Billion
Market Capitalization	$41.95 Million USD

Valuation Analysis

Below Book Valuation: The market values Hikma Pharmaceuticals PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Hikma Pharmaceuticals PLC's assets grew by 9.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Hikma Pharmaceuticals PLC (2002–2024)

The table below shows the annual total assets of Hikma Pharmaceuticals PLC from 2002 to 2024.

Year	Total Assets	Change
2024-12-31	GBX5.13 Billion ≈ $624.54K	+9.68%
2023-12-31	GBX4.68 Billion ≈ $569.42K	+4.67%
2022-12-31	GBX4.47 Billion ≈ $543.99K	+2.26%
2021-12-31	GBX4.37 Billion ≈ $531.95K	+5.73%
2020-12-31	GBX4.13 Billion ≈ $503.11K	+5.22%
2019-12-31	GBX3.93 Billion ≈ $478.17K	+12.38%
2018-12-31	GBX3.50 Billion ≈ $425.48K	+3.22%
2017-12-31	GBX3.39 Billion ≈ $412.22K	-22.35%
2016-12-31	GBX4.36 Billion ≈ $530.85K	+68.00%
2015-12-31	GBX2.60 Billion ≈ $315.98K	+15.37%
2014-12-31	GBX2.25 Billion ≈ $273.88K	+16.69%
2013-12-31	GBX1.93 Billion ≈ $234.70K	+11.50%
2012-12-31	GBX1.73 Billion ≈ $210.50K	+9.80%
2011-12-31	GBX1.58 Billion ≈ $191.71K	+41.21%
2010-12-31	GBX1.12 Billion ≈ $135.76K	+9.10%
2009-12-31	GBX1.02 Billion ≈ $124.44K	+5.82%
2008-12-31	GBX966.46 Million ≈ $117.59K	+8.10%
2007-12-31	GBX894.04 Million ≈ $108.78K	+83.07%
2006-12-31	GBX488.36 Million ≈ $59.42K	+22.71%
2005-12-31	GBX397.96 Million ≈ $48.42K	+61.46%
2004-12-31	GBX246.48 Million ≈ $29.99K	+109.13%
2003-12-31	GBX117.86 Million ≈ $14.34K	+24.25%
2002-12-31	GBX94.86 Million ≈ $11.54K	--

About Hikma Pharmaceuticals PLC

LSE:HIK UK Drug Manufacturers - Specialty & Generic

Market Cap

$41.95 Million

GBX344.80 Billion GBX

Market Cap Rank

#22675 Global

#178 in UK

Share Price

GBX1557.00

Change (1 day)

+0.84%

52-Week Range

GBX1191.00 - GBX1851.00

All Time High

GBX2408.28